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SERUM levels of IL-1b , IL-6 and TNF-a were measured in
48 healthy, termed neonates on the 1st (N1), 5th (N5)
and 40th (N40) day after birth, compared with those
in  maternal  serum  (MS),  umbilical  cord  (UC)  and
adult  controls.  Cytokine  values  in  N1  and  N5  were
significantly  elevated,  than  those  in  UC  and  in
controls  (P<0.0001).  IL-1b and  IL-6  declined  sig-
nificantly  from  N1  to  N40  (P<0.0001),  while  TNF-a
increased significantly from N1  to N5  and  declined
thereafter.  MS` IL-1b and  IL-6,  but  not  MS` TNF-a ,
were  significantly  higher  than  those  of  controls
(P<0.0001).  IL-1b values  depended  on  the  mode  of
delivery. In conclusion, the increased concentrations
of IL-1b , IL-6 and TNF-a during the perinatal period
might suggest their involvement in an inflammation-
like process during  normal  parturition,  and  reflect
also  a  newborn  immune  response  to  the  stress  of
delivery and environmental changes.
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Introduction
The  inflammatory  cytokines,  interleukin-1b (IL-1b ),
interleukin-6  (IL-6)  and  tumour  necrosis  factor-a
(TNF-a ) are important mediators of host response to
stress and infection. All three cytokines have already
been found in cells, tissues and fluids associated with
pregnancy.
1–5 It has been hypothesized that IL-1b may
play a significant role in the embryogenesis, develop-
ment and differentiation of the fetus by regulating the
growth and differentiation of tissues and/or organs.
2
Moreover,  IL-  1b ,  stimulating  prostaglandin  biosyn-
thesis by intrauterine tissues, may signal the onset of
labour and also strongly upregulate IL-6 production.
In term pregnancy IL-6 may orchestrate biochemical,
immunological  and  physiological  changes  that  con-
tribute  to  maternal  and  fetal  survival.
3 In  addition,
TNF-a , detected in the placenta, amniotic fluid and
decidua,  may  contribute  to  the  regulation  of  cell
proliferation at the uteroplacental unit.
6,7
Elevated values of IL-1b , IL-6 and TNF-a during both
term and preterm labour have already been reported
in  amniotic  fluid  samples,
2,3,8–11 in  maternal
serum
7,12–14 and  in  cervicovaginal  secretions;
15 –16
but,  little  is  known  about  the  presence  of  these
inflammatory cytokines in early neonatal life. For this
reason, our aim was to study the concentrations of IL-
1b , IL-6 and TNF-a in newborn infant  serum on the
first days after birth, compared with those in maternal
and umbilical cord serum during parturition, in order
to investigate the changes of all three inflammatory
cytokines during the perinatal period.
Patients and methods
This study was approved by the Ethics Committee of
the Areteion Teaching  Hospital.  Following  informed
maternal  consent,  peripheral  blood  samples  were
collected from 48 healthy, termed neonates (clinical
characteristics in the Table 1), during the 1st (N1), the
5th (N5) and the 40th (N40) days after birth. In 25 of
these  cases,  maternal  serum  (MS)  during  the  first
stage of labour and umbilical cord (UC) serum in the
second  stage  of  labour  were  also  obtained.  Serum
samples  from  25  healthy  adults  were  also  analysed
simultaneously, as controls.
Clinical examination of neonates, their mothers and
controls,  as  well  as  serum  reactive  protein  (CRP)
determinations were performed and all subjects were
judged infection-free.
Blood  samples,  collected  in  pyrogen-free  tubes,
were  centrifuged  at  once  after  clotting  and  stored
aliquotted  in  –30°C  until  assay. All  three  cytokines
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Table 1. Clinical characteristics of the studied neonates
Sex: Females n = 28
Males n = 20
Birthweight (mean, range) 3322g (2300–4380g)
Weeks of pregnancy (mean, range) 40 (37–42)
Mode of delivery
elective caesarean section n = 13
urgent caesarean section n = 6
vaginal delivery n = 29
Apgar scores 9–10were determined using solid phase sandwich enzyme
immunoassays. Sensitivity,  interassay  CV% and  trade
names were, for IL-1b : 4.3 pg/ml, 8.2, Biokine® IL-1b ;
for IL- 6: 0.7 pg/ml, 4.4, Biotrak  IL-6 Amersham Life
Science;  and  for TNF-a :  3.0pg/ml,  8.2, TNF-a EAS-
IA
TM, Medgenix Diagnostics.
Data were analysed using non parametric methods,
as they did  not show a  normal distribution (Kolmo-
gorov-Smyrnov test). A Wilcoxon paired or non paired
test,  as  appropriate,  was  used  in  comparing  the
distribution  of  cytokines  in  the  different  serum
samples,  while  Kruskal-Wallis  ANOVA  was  used  to
compare the cytokine values among the three groups
according to the mode of delivery. Correlations were
evaluated with Spearman rank correlation coefficients.
Results
Cytokine concentrations, as median values and ranges,
in the different serum samples are given in Table 2.
d All three  cytokines  were  significantly  elevated in
the neonatal samples N1 and N5, compared with
those  found  in  UC  and  in  adult  controls
(P<0.0001).
d Neonatal  serum values of IL-1b and IL-6 declined
significantly  from  N1  to  N40  (P<0.0001),  while
those of TNF-a increased significantly from N1 to
N5 (P<0.0001) and declined thereafter.
d Umbilical cord values of TNF-a were significantly
higher  than  those  in  controls  (P<0.0001),  but
lower than in N40. The UC values of IL-1b and IL-6
were higher, not significantly though, than those in
adult controls and in neonatal samples N40.
d Maternal serum IL-1b and IL-6, but not TNF-a values
were  significantly  higher  than  those  in  controls
(P<0.0001).
d Maternal serum IL-1b values were also significantly
higher than those in N1 (P<0.0001), while those of
IL-6  and  TNF-a were  significantly  lower
(P<0.0001).
d Serum IL-1b values were strongly dependent on the
mode of delivery in UC (P<0.03), in N1 (P<0.001),
in  MS  (P<0.02),  and  marginally  in  N5  samples
(P<0.055),  the  lowest  being  found  in  the  cases
with elective caesarean section and the highest in
those with an urgent one.
d A significant correlation was observed between IL-
1b values in MS and UC (r=0.77; P<0.001), in MS
and  N1  (r=0.6;  P<0.009),  in  MS  and  N5  (r=0.5;
P<0.03)  and  especially  in  N1  and  N5  (r=0.9;
P<0.0001).  No  correlation  was  found  between
either IL-6 or TNF-a values in the same samples.
d Serum  values  of  IL-1b and  TNF-a in  N1  were
strongly interrelated (r=0.7; P<0.01).
Discussion
The  patterns  of  inflammatory  cytokines  IL-1b ,  IL-6
and TNF-a in  newborn  infants  during  the  perinatal
period demonstrated significant changes in cytokine
values, related to the time after birth. TNF-a presented
significantly elevated umbilical cord values, compared
with those in controls and in maternal serum, with a
significant increase in neonatal serum on the 1st and
further on  the 5th  day  after  birth,  declining  slowly
thereafter. The  concentrations  of  IL-1b and  IL-6  in
umbilical cord were also higher, marginally though,
than those in controls, increasing markedly further on
the 1st day after birth and declining thereafter, until
normalization 40 days later.
These data, concerning elevated values of all three
inflammatory cytokines in healthy newborn  infants,
are the new findings of this study and may possibly
reflect an immune response of neonates to the stress
of delivery and environmental influences during the
early neonatal life. This hypothesis is also supported
by the dependence of IL-1b values in UC and N1 on
the mode of delivery and  the elevation  of cytokine
values in UC, mainly of TNF-a , compared with those
in controls.
To the best of our knowledge, serum levels of these
inflammatory cytokines in healthy, non-infected neo-
nates during the early neonatal  period are reported
here  for  the  first  time.  Since  all  these  pregnancies
were  uneventful  and  led  to  the  birth  of  healthy,
termed newborns, these levels may be considered to
be a good reflection of the normal range.
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Table 2. Cytokine values (median, range) in maternal serum (MS), umbilical cord (UC) and newborn infant serum, in the 1st
(N1), 5th (N5) and 40th (N40) days after birth and in adult controls
Samples n IL-1b
pg/ml
Significance
P*
IL-6
pg/ml
Significance
P*
TNF-a
pg/ml
Significance
P*
MS 25 188 (15–464) 0.0001 5.7 (0.9–68) 0.0001 5.8 (2.5–10) NS
UC 25 20.6 (0.0–148) 0.055 2.1 (0.7–36.0) 0.06 14.5 (8–19) 0.0001
N1 48 58.0 (14.5–240) 0.0001 21.0 (6.0–680) 0.0001 29.2 (17–54) 0.0001
N5 48 30.0 (0.0–160) 0.0001 6.7 (2.4–10.5) 0.0001 42.0 (18–79) 0.0001
N40 13 0.8 (0.0–80) NS 1.07 (0.7–11) NS 30.0 (27–44) 0.0001
Controls 25 14.0 (0.0–76) 1.8 (0.5–2.6) 4.8 (0.0–1.3)
*Compared with controls.It  has  been  hypothesized  that  the  presence  of
increased TNF-a values in pyar and breast milk may
induce the developmental and maturational processes
of the immune system in neonates.
17,18 However, our
TNF-a values in umbilical cord showed a significant
elevation already during birth, before breast feeding,
strengthening  our  suggestion,  that  normal  term
labour  itself,  might  constitute  an  inflammation-like
process, that promotes the activation of the newborn
immune system.
Similarly, we have already reported elevated serum
values  of  soluble  interleukin-2  receptors  (sIL-2R)  in
umbilical  cord  and  in  serum  samples  from  healthy
term neonates on the 1st and 5th < day after birth,
increasing  progressively  from  the  1st  to  the  3rd
sample  and  strongly  dependent  on  the  mode  of
delivery.
19 The elevation of this cytokine, a character-
istic marker of immune activation,  was attributed to
the  dynamic  expansion  of  the  neonatal  immune
system, in response to environmental changes, during
and  after  birth  in  the  early  neonatal  period.  This
phenomenon  was also reflected in  the  elevation  of
other growth factors, as we have previously reported
for angiogenin levels in the perinatal period.
20
We  have  recently  also  found,  however,  soluble
intercellular adhesion molecule-1 (sICAM-1) levels in
neonatal serum samples on the 1st day of life to be
lower  than  those  in  controls,  though  increasing
progressively thereafter and exceeding those of con-
trols  1  month  after  birth.
21 These  differences  in
expression  of  cytokines  during  parturition  may  be
due  to  their  differentiated  roles  in  the  cytokine
cascade during inflammation and immune process.
Moreover,  in  agreement  with  previous
reports,
7,18,22–24 this  study  demonstrated  very
increased values of IL-1b and IL-6, but not of TNF-a , in
maternal circulation during the first stage of labour.
The values of IL-1b were strongly related to the mode
of  delivery, a  finding  consistent  with  the  dominant
role of this cytokine in the initiation of parturition.
1–3
The elevation of maternal serum IL-1b and IL-6 values
seems to reflect a systemic reaction in the mother to
her  fetus  and  might  be  analogous  to  the  cytokine
increase  observed  in  the  serum  of  renal  transplant
recipients, before acute rejection of the graft.
25 The
final increase at the onset of labour could be a similar
‘sign  of  rejection’.
7 Another  possible  explanation
might be the physical effort of giving birth, because
prolonged exercise is associated with increased pro-
duction  of IL-6  from stimulated blood mononuclear
cells.
26
In  contrast,  the  low  values  of TNF-a in  maternal
serum suggest a paracrine action for this cytokine in
maternal and fetal tissues, as they regulate the growth
of  trophoblast  during  pregnancy  and  contribute  to
the immune processes, associated with labour.
24
Generally, IL-1b , IL-6 and TNF-a released by chor-
ion, amnion and decidua and acting on these mem-
branes, maternal serum cytokine values reflect func-
tions  that  take  place  in  the  gestational  tissues  and
depend on the permeability of these tissues by these
proteins. Thus, our elevated maternal serum IL-6 and
low TNF-a are in agreement with a previous report,
27
regarding  the  permeability  of  fetal  membranes  by
these cytokines. In contrast, our results on increased
maternal  serum  IL-1b values do not agree with  the
latter study.
In conclusion, the presence of increased inflamma-
tory cytokines IL-1b , IL-6 and TNF-a during the early
neonatal period (a) suggests their contribution to the
immune system alterations that may signal or propa-
gate the onset of parturition and  (b) reflects also a
neonatal  immune response to the stress of delivery
and  environmental  changes  in  the  first  days  after
birth.
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